DR Horton Share Price

Equities

DHI

US23331A1097

Homebuilding

Market Closed - Nyse 21:00:02 24/05/2024 BST 5-day change 1st Jan Change
144.6 USD +1.26% Intraday chart for DR Horton -4.54% -4.84%
Sales 2024 * 36.92B 2,899B Sales 2025 * 39.41B 3,094B Capitalization 47.63B 3,739B
Net income 2024 * 4.72B 371B Net income 2025 * 5B 393B EV / Sales 2024 * 1.33 x
Net Debt 2024 * 1.36B 107B Net Debt 2025 * 1.02B 80.13B EV / Sales 2025 * 1.23 x
P/E ratio 2024 *
10.2 x
P/E ratio 2025 *
9.31 x
Employees 13,450
Yield 2024 *
0.83%
Yield 2025 *
0.89%
Free-Float 73.76%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.26%
1 week-4.54%
Current month+1.49%
1 month-1.03%
3 months-1.01%
6 months+13.45%
Current year-4.84%
More quotes
1 week
142.29
Extreme 142.29
151.93
1 month
140.99
Extreme 140.99
157.73
Current year
138.83
Extreme 138.83
165.75
1 year
100.08
Extreme 100.08
165.75
3 years
59.25
Extreme 59.25
165.75
5 years
25.51
Extreme 25.51
165.75
10 years
19.29
Extreme 19.29
165.75
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 31/12/98
Chairman 68 31/12/87
Director of Finance/CFO 58 31/12/97
Members of the board TitleAgeSince
Director of Finance/CFO 58 31/12/97
Director/Board Member 78 22/01/14
Director/Board Member 73 19/04/21
More insiders
Date Price Change Volume
24/05/24 144.6 +1.26% 1,102,436
23/05/24 142.8 -1.22% 1,906,847
22/05/24 144.6 -3.21% 3,094,421
21/05/24 149.4 -0.27% 1,622,311
20/05/24 149.8 -1.13% 1,390,978

Delayed Quote Nyse, May 24, 2024 at 09:00 pm

More quotes
D.R. Horton, Inc. is one of the leading American single-family homebuilders. Net sales break down by activity as follows: - construction of single-family homes and development of lots (90.4%): home sales (detached homes, attached homes, etc.; operating under the names D.R. Horton, America's Builder, Emerald Homes, Express Homes, Freedom Homes and Pacific Ridge Homes) and lot sales; - property rental (7.3%); - supply of financial services (2.3%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
144.6 USD
Average target price
169.8 USD
Spread / Average Target
+17.41%
Consensus